Kathmere Capital Management »

Black Diamond Therapeutics shares owned by Kathmere Capital Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Kathmere Capital Management from 13F filings

Historical chart of Kathmere Capital Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Kathmere Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Kathmere Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $92k 24k 3.79

More positions owned by Kathmere Capital Management

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Value (VLUE)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Msci Usa Mmentm (MTUM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Ibonds Dec2026 (IBDR)
Ishares Tr Ibonds Dec25 Etf (IBDQ)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Tr Ibds Dec28 Etf (IBDT)
Apple (AAPL)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ea Series Trust Alpha Arch 1-3 (BOXX)

View all positions for Kathmere Capital Management

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics